Diagnostik bei Myalgien - Deutsche Gesellschaft für Muskelkranke ...

21. Timpl, P., et al., Impaired stress response and reduced anxiety in mice lacking a
functional corticotropin-releasing hormone receptor 1. Nat Genet, 1998. 19(2): p.
162-6.
22. Melzack, R., The McGill Pain Questionnaire: major properties and scoring methods.
Pain, 1975. 1(3): p. 277-99.
23. Stein, C. and G. Mendl, The German counterpart to McGill Pain Questionnaire. Pain,
1988. 32(2): p. 251-5.
24. George, A., et al., Musculosceletal pain in myotonic dystrophy type 2. Arch Neurol,
2004: p. im Druck.
25. Bohner, J., et al., Stability of macro creatine kinases and creatine kinase isoenzymes
compared: heat inactivation test for determination of thermostable creatine kinases. J
Clin Chem Clin Biochem, 1981. 19(10): p. 1021-6.
26. Pointner, H., Enzymaktivitäten im Plasma, in Laboratoriumsdiagnostik, G.G. Deutsch
E, Wenger R, Editor. 1992, Medizinisch wissenschaftliche Buchreihe von Schering. p.
781-783.
27. Lindner, A. and S. Zierz, Rhabdomyolyse und Myoglobinurie. Nervenarzt, 2003.
74(6): p. 505-15.
28. Lindner, A., et al., Acute compartment syndrome after forearm ischemic work test in a
patient with McArdle's disease. Neurology, 2001. 56(12): p. 1779-80.
29. Hogrel, J.Y., et al., A non-ischemic forearm exercise test for the screening of patients
with exercise intolerance. Neurology, 2001. 56(12): p. 1733-8.
30. Kazemi-Esfarjani, P., et al., A nonischemic forearm exercise test for McArdle disease.
Ann Neurol, 2002. 52(2): p. 153-9.
31. Heuss, D., Muskelschmerzen. Nervenheilkunde, 1998. 17: p. 201-6.
32. Heuss, D., D. Claus, and B. Neundörfer, Fibrillations in regenerating muscle in
dystrophic myopathies. Clin Neuropathol, 1996. 15(4): p. 200-8.
33. Lofberg, M., et al., Antimyosin scintigraphy compared with magnetic resonance
imaging in inflammatory myopathies. Arch Neurol, 1998. 55(7): p. 987-93.
34. Reimers, C.D. and H. Kele, Muskelsonographie bei neuromuskulären Erkrankungen.
Orthopäde, 2002. 31(2): p. 165-71.
35. Mastaglia, F.L., et al., Inflammatory myopathies: clinical, diagnostic and therapeutic
aspects. Muscle Nerve, 2003. 27(4): p. 407-25.
36. Park, J.H. and N.J. Olsen, Utility of magnetic resonance imaging in the evaluation of
patients with inflammatory myopathies. Curr Rheumatol Rep, 2001. 3(4): p. 334-45.
37. Beggs, A.H., et al., Detection of 98% of DMD/BMD gene deletions by polymerase
chain reaction. Hum Genet, 1990. 86(1): p. 45-8.
38. Mendell, J.R., et al., Diagnosis of Duchenne dystrophy by enhanced detection of small
mutations. Neurology, 2001. 57(4): p. 645-50.
39. Niiyama, T., et al., Diagnosis of dystrophinopathy by skin biopsy. Muscle Nerve,
2002. 25(3): p. 398-401.
40. Mills, K.R. and R.H. Edwards, Investigative strategies for muscle pain. J Neurol Sci,
1983. 58(1): p. 73-8.